Immune Cell Infiltration of the Primary Tumor Microenvironment Predicted the Treatment Outcome of Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients

BACKGROUND: With the interest in cancer immunotherapy, it may be possible to combine immunotherapy with bevacizumab and chemotherapy. We evaluated whether tumor-infiltrating immune cells are associated with the efficacy of chemotherapy with or without bevacizumab for the treatment of metastatic colo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yixing, Dong, Jun, Quan, Qi, Liu, Shousheng, Chen, Xiuxing, Cai, Xiuyu, Qiu, Huijuan, Zhang, Bei, Guo, Guifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873592/
https://www.ncbi.nlm.nih.gov/pubmed/33585196
http://dx.doi.org/10.3389/fonc.2020.581051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873592/
https://www.ncbi.nlm.nih.gov/pubmed/33585196
http://dx.doi.org/10.3389/fonc.2020.581051

Ejemplares similares